Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $656,000 Position in Bio-Techne Corp $TECH
05:16am, Monday, 05'th Jan 2026
VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Bio-Techne Corp (NASDAQ: TECH) in the undefined quarter, according to the company in its most recent filing with the SEC. The in
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
07:00am, Tuesday, 23'rd Dec 2025
MINNEAPOLIS , Dec. 23, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Health
Corient Private Wealth LLC Reduces Stake in Bio-Techne Corp $TECH
03:54am, Thursday, 18'th Dec 2025
Corient Private Wealth LLC reduced its holdings in Bio-Techne Corp (NASDAQ: TECH) by 9.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned
CMB.TECH INVESTS IN CHINESE AMMONIA SUPPLY
02:27am, Tuesday, 16'th Dec 2025
Antwerp, Dec. 16, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMBT”, “CMB.TECH” or “the Company”) is pleased to announce the
Bamco Inc. NY Has $143.81 Million Stake in Bio-Techne Corp $TECH
04:28am, Saturday, 13'th Dec 2025
Bamco Inc. NY trimmed its position in Bio-Techne Corp (NASDAQ: TECH) by 14.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund
Cerity Partners LLC Boosts Stake in Bio-Techne Corp $TECH
03:50am, Friday, 12'th Dec 2025
Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ: TECH) by 20.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commissi
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
06:30am, Thursday, 11'th Dec 2025
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced a strategic
Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis
06:30am, Tuesday, 09'th Dec 2025
Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for expanded multiplexing Enables up to 24 targets per sample and supports com
Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript
05:57am, Tuesday, 09'th Dec 2025
Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript
Bio-Techne Corp $TECH Position Reduced by Brown Advisory Inc.
04:14am, Saturday, 06'th Dec 2025
Brown Advisory Inc. reduced its position in Bio-Techne Corp (NASDAQ: TECH) by 7.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange
Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
06:43pm, Wednesday, 03'rd Dec 2025
Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
02:33pm, Tuesday, 02'nd Dec 2025
Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
CMB.TECH NV (CMBT) Q3 2025 Earnings Call Transcript
12:23pm, Wednesday, 26'th Nov 2025
CMB.TECH NV ( CMBT ) Q3 2025 Earnings Call November 26, 2025 8:00 AM EST Company Participants Alexander Saverys - CEO & Member of Management Board Ludovic Saverys - CFO & Member of Management Board En
CMB.TECH announces Q3 2025 results
01:05am, Wednesday, 26'th Nov 2025
CMB.TECH ANNOUNCES Q3 2025 RESULTS SOFT SUMMER, FOLLOWED BY ROARING TANKER AND DRY BULK MARKETS ANTWERP, Belgium, 26 November 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NY
Bio-Techne to Present at Upcoming Investor Conferences
07:00am, Tuesday, 25'th Nov 2025
MINNEAPOLIS , Nov. 25, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 8th Annual Evercore Healthcare Conference
